Skip to main content

Table 4 Measurements used, treatment/management options and HCP involvement

From: Exploring the biopsychosocial impact of hypermobility spectrum disorders and Ehlers-Danlos syndrome in an adult population: a protocol for a scoping review

Heading

Data extraction

Study details

Author, year

Measurements

Reported outcome measures used to assess the biopsychosocial impact (e.g. anxiety and depression — Hospital Anxiety and Depression Scale)

Management

Reported treatment and management options

HCP involvement

Reported HCP involvement (e.g. gastroenterologists, cardiologists)